Literature DB >> 18495853

Prevalence and sequence diversity of a factor required for actin-based motility in natural populations of Burkholderia species.

Chayada Sitthidet1, Joanne M Stevens, Narisara Chantratita, Bart J Currie, Sharon J Peacock, Sunee Korbsrisate, Mark P Stevens.   

Abstract

Actin-based motility of the melioidosis pathogen Burkholderia pseudomallei requires BimA. We report a high degree of conservation of bimA in 99 B. pseudomallei isolates from the area of endemicity. A geographically restricted subset of B. pseudomallei isolates harbored a B. mallei-like bimA allele (12.1%), confounding a differential diagnostic test based on amplification of species-specific bimA regions.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18495853      PMCID： PMC2446894          DOI： 10.1128/JCM.00368-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  32 in total

1.  A Rickettsia WASP-like protein activates the Arp2/3 complex and mediates actin-based motility.

Authors:  Robert L Jeng; Erin D Goley; Joseph A D'Alessio; Oleg Y Chaga; Tatyana M Svitkina; Gary G Borisy; Robert A Heinzen; Matthew D Welch
Journal:  Cell Microbiol       Date:  2004-08       Impact factor: 3.715

2.  Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei.

Authors:  Matthew T G Holden; Richard W Titball; Sharon J Peacock; Ana M Cerdeño-Tárraga; Timothy Atkins; Lisa C Crossman; Tyrone Pitt; Carol Churcher; Karen Mungall; Stephen D Bentley; Mohammed Sebaihia; Nicholas R Thomson; Nathalie Bason; Ifor R Beacham; Karen Brooks; Katherine A Brown; Nat F Brown; Greg L Challis; Inna Cherevach; Tracy Chillingworth; Ann Cronin; Ben Crossett; Paul Davis; David DeShazer; Theresa Feltwell; Audrey Fraser; Zahra Hance; Heidi Hauser; Simon Holroyd; Kay Jagels; Karen E Keith; Mark Maddison; Sharon Moule; Claire Price; Michael A Quail; Ester Rabbinowitsch; Kim Rutherford; Mandy Sanders; Mark Simmonds; Sirirurg Songsivilai; Kim Stevens; Sarinna Tumapa; Monkgol Vesaratchavest; Sally Whitehead; Corin Yeats; Bart G Barrell; Petra C F Oyston; Julian Parkhill
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

3.  Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation.

Authors:  Allen C Cheng; Daniel Godoy; Mark Mayo; Daniel Gal; Brian G Spratt; Bart J Currie
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

4.  Sequence analysis of the actA gene of Listeria monocytogenes isolated from human.

Authors:  K Moriishi; M Terao; M Koura; S Inoue
Journal:  Microbiol Immunol       Date:  1998       Impact factor: 1.955

5.  Patterns of large-scale genomic variation in virulent and avirulent Burkholderia species.

Authors:  Catherine Ong; Chia Huey Ooi; Dongling Wang; Hweeling Chong; Kim Chong Ng; Fiona Rodrigues; May Ann Lee; Patrick Tan
Journal:  Genome Res       Date:  2004-11       Impact factor: 9.043

6.  The tandem repeat domain in the Listeria monocytogenes ActA protein controls the rate of actin-based motility, the percentage of moving bacteria, and the localization of vasodilator-stimulated phosphoprotein and profilin.

Authors:  G A Smith; J A Theriot; D A Portnoy
Journal:  J Cell Biol       Date:  1996-11       Impact factor: 10.539

7.  The evolutionary history of Shigella and enteroinvasive Escherichia coli revised.

Authors:  Patricia Escobar-Páramo; Catherine Giudicelli; Claude Parsot; Erick Denamur
Journal:  J Mol Evol       Date:  2003-08       Impact factor: 2.395

8.  Structural flexibility in the Burkholderia mallei genome.

Authors:  William C Nierman; David DeShazer; H Stanley Kim; Herve Tettelin; Karen E Nelson; Tamara Feldblyum; Ricky L Ulrich; Catherine M Ronning; Lauren M Brinkac; Sean C Daugherty; Tanja D Davidsen; Robert T Deboy; George Dimitrov; Robert J Dodson; A Scott Durkin; Michelle L Gwinn; Daniel H Haft; Hoda Khouri; James F Kolonay; Ramana Madupu; Yasmin Mohammoud; William C Nelson; Diana Radune; Claudia M Romero; Saul Sarria; Jeremy Selengut; Christine Shamblin; Steven A Sullivan; Owen White; Yan Yu; Nikhat Zafar; Liwei Zhou; Claire M Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

9.  The RickA protein of Rickettsia conorii activates the Arp2/3 complex.

Authors:  Edith Gouin; Coumaran Egile; Pierre Dehoux; Véronique Villiers; Josephine Adams; Frank Gertler; Rong Li; Pascale Cossart
Journal:  Nature       Date:  2004-01-29       Impact factor: 49.962

10.  iactA of Listeria ivanovii, although distantly related to Listeria monocytogenes actA, restores actin tail formation in an L. monocytogenes actA mutant.

Authors:  E Gouin; P Dehoux; J Mengaud; C Kocks; P Cossart
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441
View more
  25 in total

1.  Use of a recombinant burkholderia intracellular motility a protein for immunodiagnosis of glanders.

Authors:  Subodh Kumar; Praveen Malik; Shailendra Kumar Verma; Vijai Pal; Vandana Gautam; Chiranjay Mukhopadhyay; Ganga Prasad Rai
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

2.  Molecular characterization of clinical Burkholderia pseudomallei isolates from India.

Authors:  Chiranjay Mukhopadhyay; Mirjam Kaestli; Kalwaje Eshwara Vandana; Krishna Sushma; Mark Mayo; Leisha Richardson; Apichai Tuanyok; Paul Keim; Daniel Godoy; Brian G Spratt; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

Review 3.  Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion.

Authors:  Samantha J Dando; Alan Mackay-Sim; Robert Norton; Bart J Currie; James A St John; Jenny A K Ekberg; Michael Batzloff; Glen C Ulett; Ifor R Beacham
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

Review 4.  Melioidosis: molecular aspects of pathogenesis.

Authors:  Joshua K Stone; David DeShazer; Paul J Brett; Mary N Burtnick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10-14       Impact factor: 5.091

5.  Actin-based motility of bacterial pathogens: mechanistic diversity and its impact on virulence.

Authors:  Julie E Choe; Matthew D Welch
Journal:  Pathog Dis       Date:  2016-09-20       Impact factor: 3.166

6.  Development of reagents and assays for the detection of pathogenic Burkholderia species.

Authors:  Omar Qazi; Mridula Rani; Annie J Gnanam; Thomas W Cullen; Christopher M Stead; Haley Kensing; Kate McCaul; Sarah Ngugi; Joann L Prior; Alexandria Lipka; Judit M Nagy; C Whitlock Gregory; Barbara M Judy; Sarah V Harding; Richard W Titball; Sachdev S Sidhu; M Stephen Trent; G Barrie Kitto; Alfredo Torres; D Mark Estes; Brent Iverson; George Georgiou; Katherine A Brown
Journal:  Faraday Discuss       Date:  2011       Impact factor: 4.008

7.  Identification of motifs of Burkholderia pseudomallei BimA required for intracellular motility, actin binding, and actin polymerization.

Authors:  Chayada Sitthidet; Sunee Korbsrisate; Abigail N Layton; Terence R Field; Mark P Stevens; Joanne M Stevens
Journal:  J Bacteriol       Date:  2011-02-18       Impact factor: 3.490

8.  Actin-based motility of Burkholderia thailandensis requires a central acidic domain of BimA that recruits and activates the cellular Arp2/3 complex.

Authors:  Chayada Sitthidet; Joanne M Stevens; Terence R Field; Abigail N Layton; Sunee Korbsrisate; Mark P Stevens
Journal:  J Bacteriol       Date:  2010-08-06       Impact factor: 3.490

9.  The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study.

Authors:  Bart J Currie; Linda Ward; Allen C Cheng
Journal:  PLoS Negl Trop Dis       Date:  2010-11-30

10.  Burkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the Trigeminal Nerve after Intranasal Inoculation.

Authors:  James A St John; Heidi Walkden; Lynn Nazareth; Kenneth W Beagley; Glen C Ulett; Michael R Batzloff; Ifor R Beacham; Jenny A K Ekberg
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.